TheEdgeResearch
Home / Stocks / VSBC

VitaSpring Biomedical Co. Ltd. (VSBC)

OTC Healthcare Biotechnology
$0.01 ▲ +0.00%
Market Cap
$2.3M
Sector
Healthcare
Industry
Biotechnology
Beta
-2.48
52-Wk Range
0.0111-1
CEO
Ssu-Chuan Lai
Country
US
Currency
USD

VitaSpring Biomedical Co. Ltd. operates in the Biotechnology industry of the Healthcare sector, headquartered in Riverside, CA, US. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $2.3M. On trailing twelve-month figures it carries a trailing P/E of -5.55, a net margin of 0.0%. Its beta of -2.48 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-5.55
Price / Sales
0.00
Price / Book
-0.51
EV / EBITDA
-5.88
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2019-11-13
Headquarters
Riverside, CA, US
About VitaSpring Biomedical Co. Ltd.

VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical solutions derived from cellular medicine. It previously operated as Shemn Corp. before rebranding as VitaSpring Biomedical Co. Ltd. in February 2020. The company was established in 2016 and its main operations are based in Irvine, California.

Comparable companies

VitaSpring Biomedical Co. Ltd. is most often compared with the following Healthcare names:

AURXGGBXFIUGNFKNTPFMSCLFPBIGFPOLBFSHIEFSPHRYTOKIF
More research on VSBC
VSBC technical analysis VSBC TheEdge Score Compare against peers
Open full interactive analysis & DCF →